Travera

Live-cell testing that measures which drugs actually work on the tumor

Verified partner

Testing

Your records go with you, in one click

Live-cell testing that measures which drugs actually work on the tumor. OpenCancer pre-fills the Travera intake from your records and carries your consent, so nothing gets retyped and nothing moves without your say-so.

Why Travera exists

Travera tests your live cancer cells against FDA-approved drugs to identify which treatments have the best chance of working for your specific cancer. The technology was developed at MIT and measures how tumor cells respond to up to 20 physician-selected drugs from a panel of more than 100. In early studies the test matched actual treatment responses in 80% of cases.

Results in 2 days after sample collectionCLIA-certified laboratory · ID 22D2229321

1
Your physician orders the test
Your doctor selects up to 20 drugs to evaluate from a panel of 100+ FDA-approved options.
2
You provide a sample
A fresh sample of your cancer cells is collected and shipped to the lab.
3
Live cells meet real drugs
The lab measures how your living cancer cells respond to each selected drug.
4
Results in 2 days
Your ordering physician receives the responses to help guide the treatment decision.

Prefer the source? Travera's own site has more.

Connect with Travera via OpenCancer

Direct intake integration: your records, case summary, and consent flow to Travera in one step — nothing retyped, nothing sent without your sign-off.

Connect now →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Travera handles billing.

We don't have confirmed insurance details for Travera yet. Start a coverage check with your plan, or contact the provider directly.

Ask about this service

Answers grounded in Travera's details here. Educational only; your oncologist directs treatment.

Common questions in this category

Based on what other patients have asked.

When is a pet/ct scan advised for a new breast cancer diagnosis

Breast Cancer

Does the specific variant of the CHEk2 mutation make a difference? I have the Ashkenazi Founder variant.

Is the CHEK2 mutation related to prostate cancer

What lifestyle changes are recommended for Prostate - Early Stage patients

Prostate - Early Stage

What should I know as a newly diagnosed CRC patient

Colorectal Cancer

What should I ask my oncologist after a new diagnosis

Also consider

Other providers in similar categories.

BostonGene

5 offerings

Target immunotherapies with the highest likelihood of response

Tempus

5 offerings

Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.

Foundation Medicine

4 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.